trending Market Intelligence /marketintelligence/en/news-insights/trending/Jyd_4JmnjT_TvZf4hW0l7w2 content esgSubNav
In This List

BioPharmX adds board member

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


BioPharmX adds board member

BioPharmX Corp.'s board elected Charles Vontz as an independent board member, effective Jan. 17.

Vontz was most recently the president and CEO of Topica Pharmaceuticals.

The company's board now comprises four directors, three of whom are independent.